Jvc.Hm
JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.
Business. JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.
JVC.HM maintains a debt-to-equity ratio of 0.51, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.78, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's operating cash flow is negative at -88.5 billion VND, which raises concerns about its ability to fund operations from core business activities.
Profitability metrics show JVC.HM has a return on equity (ROE) of 8.47% and a return on assets (ROA) of 4.66%. These figures are below the industry median for ROE and ROA in the Advanced Medical Equipment & Technology sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a few key segments and geographic regions, as disclosed in its financial segments. While the exact breakdown is not provided, the high revenue of 763.15 billion VND suggests a significant market presence. However, the lack of detailed segment data limits the ability to assess diversification risk.
Looking ahead, JVC.HM is expected to experience a modest growth trajectory, with revenue and earnings likely to remain stable in the near term. The company's free cash flow of 32.83 billion VND and capital expenditure of -41.86 billion VND suggest that it is investing in long-term growth, but the negative operating cash flow indicates potential challenges in sustaining these investments without external financing.
Risk factors for JVC.HM include its negative net cash position after accounting for total debt, which could limit its financial flexibility. The company's dilution risk is currently assessed as low, but the negative operating cash flow and high capital expenditures may necessitate future equity or debt financing, which could dilute existing shareholders.
Recent events, including filings and transcripts, have not been disclosed in the available data. However, the company's financial snapshot indicates a need for careful monitoring of its liquidity and capital structure to ensure long-term sustainability.
- JVC.HM has a balanced capital structure with a debt-to-equity ratio of 0.51.
- The company's profitability metrics are below the industry median, indicating underperformance.
- JVC.HM's liquidity position is medium, with a current ratio of 1.78.
- The company is investing in long-term growth, as evidenced by its capital expenditures.
- JVC.HM faces potential liquidity challenges due to its negative operating cash flow.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- JVC.HM Market data — financials · 2026-05-28